English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Myeloid supressor cells
Share :
ASH 2009
3 Dec 2011
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
27 Jan 2010
Views:
8490
Rating:
Save
Rate video
Prof John Harlan - University of Washington, USA
Prof John Harlan talks about the latest in myeloid supressor cells and adapting immune response by targeting the tumour micro-environment.
Categories:
Haematology oncology
Related Videos
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic...
Dr Consuelo Bertossi - University Hospital of Ulm, Ulm, Germany
27 Jun 2024
Isa-VCd induction in NDMM patients with severe renal impairment show no new...
Prof Evangelos Terpos - University of Athens, School of Medicine, Athens, Greece
26 Jun 2024
A patient-reported questionnnaire may eliminate the need for an ophthalmic exam...
Prof Evangelos Terpos - University of Athens, School of Medicine, Athens, Greece
26 Jun 2024
Novel CAR-T cell therapy shows promise against calreticulin mutant neoplasms
Dr Alexandros Rampotas - UCL Cancer Institute, London, United Kingdom
26 Jun 2024
EHA 2024: Multiple myeloma roundup
Dr Claudio Cerchione - IRCCS, Meldola, Italy
26 Jun 2024
ATRA-ATO regimen with idarubicin could become the new standard of care in high...
Dr Uwe Platzbecker - University Hospital Leipzig, Leipzig, Germany
25 Jun 2024
Belantamab mafodotin, pomalidomide and dexamethasone shows superior efficacy in...
Prof Meletios Dimopoulos - University of Athens, Athens, Greece
24 Jun 2024
Ponatinib is better than imatinib for frontline treatment of newly diagnosed...
Prof Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
24 Jun 2024
More effective treatment options required for patients with MM post...
Dr Claudio Cerchione - IRCCS, Meldola, Italy
24 Jun 2024
More from
e
cancer